Newsroom
News from UCLB
UCLB launches funding for early-stage social ventures
UCLB, part of UCL Innovation & Enterprise, launches its search for early-stage social ventures to benefit from Proof of Concept ...
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia
LONDON, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment ...
New commercialisation models to help bring more UCL discoveries to market
The launch of Portico Ventures sees the introduction of two new models for intellectual property (IP) commercialisation to support UCL ...
UCLB reaches an exclusive license agreement for the treatment of Alpha-1-Antitrypsin Deficiency
UCLB has concluded an exclusive agreement to license a collection of pre-clinical small molecule compounds for the treatment of alpha-1-antitrypsin ...
Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment
Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease ...
UCLB spinout Endomag makes The Sunday Times Tech Track 100
Congratulations to medical device spinout Endomag who has been named in The Sunday Times Tech Track 100 list. The list ...
Four UCLB spinout companies are named finalists in the European Lifestars Awards
We are delighted to announce that four UCLB spinout companies have been named finalists for the 2019 European Lifestars Awards ...
Achillies Thereapeutics raises £100 million in oversubscribed series B financing
Achilles Therapeutics, a biopharmaceutical company launched in 2016, based on work led by Professor Charles Swanton of UCL and the ...
AstronauTx Ltd secures £6.5m for Dementia Research
AstronauTx, a new biotech company building upon research from the Alzheimer’s Research UK UCL Drug Discovery Institute (DDI), has received ...
Somaserve secures IP and global commercial rights to the ‘bionic nanoparticle’ technology PolyNaut®
Somaserve Ltd, a newly founded UCLB spinout company from the UCL department of Chemistry, today announced that it has secured ...
UCLB Hosts its Annual Summer Party
On the 27th June UCLB hosted its Annual Summer Party alongside the backdrop of UCL’s historical Portico building. The evening ...
Fashion designer Sir Paul Smith sponsors Slade student’s final-year project
British fashion designer Sir Paul Smith has given a personal donation to support two UCL artists to ‘dress’ the university’s ...
UCLB spinout Senceive wins SME of the Year at The Rail Partnership Awards 2019
Senceive Ltd, a spinout from the Department of Electronic and Electrical Engineering, has been awarded the SME of the Year ...
Echopoint wins Innovators Award
Congratulations to UCL spinout Echopoint who received the Innovators Award at last night’s UCL Awards for Innovation & Enterprise 2019 ...
UCL Technology Fund leads £750k investment in Phasecraft
Parkwalk and the UCL Technology Fund are leading a £750k investment into Phasecraft, a pioneering quantum computing company, along with ...
